TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.

Name: TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.
License: Public Domain

Royal Devon and Exeter NHS Foundation Trust

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

type-2-diabetes

type 2 diabetes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143804
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.